Skip to main content

Advertisement

Table 1 Baseline clinical, demographic, histologic and metabolic characteristics of 77 patients with chronic hepatitis C

From: Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C

Patients (number) 77
Age (years) 56.1 ± 12.4
Sex [male/female] 31/46
Body mass index (kg/m2) 23.5 ± 2.9
 Male (kg/m2) 23.8 ± 2.9
 Female (kg/m2) 23.3 ± 3.1
HCV serotype [I/II] 47/30
Viral load of HCV (log IU/ml) 5.9 ± 1.1
Platelet count (×104/μl) 18.1 ± 7.2
Total cholesterol (mg/dl) 170.7 ± 38.6
Albumin (g/dl) 4.3 ± 0.4
ALT (IU/l) 64.5 ± 53.9
γ-GTP (IU/l) 50.1 ± 62.2
Diabetes [absent/present] 60/17
Hemoglobin A1c (%) 5.4 ± 0.6 (n = 75)
Fasting plasma glucose (mg/dl) 97.0 ± 22.1
Fasting insulin (μU/ml) 9.8 ± 5.7 (n = 40)
HOMA-IR 2.2 ± 1.5 (n = 40)
Leptin (ng/ml) 7.6 ± 5.1
Adiponectin (ng/ml) 9.0 ± 6.2
Resistin (ng/ml) 8.5 ± 4.6
AIM (μg/ml) 1.39 ± 0.86
Hyaluronic acid (ng/ml) 95.9 ± 114.0 (n = 75)
α-fetoprotein (ng/ml) 7.1 ± 11.2
Histologic characteristics  
 Activity [A0-1/2-3] 32/45
 Fibrosis [F0-1/2-3] 36/41
 Steatosis [<5%/≥5%] 59/18
  1. Data are shown as the means ± standard deviations or number.
  2. HCV, hepatitis C virus; ALT, alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase; HOMA-IR, homeostasis model assessment-insulin resistance; AIM, apoptosis inhibitor of macrophage.